Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 18/20 | 0.52 |
| ▸ | CNR2 | P34972 | 14/20 | 0.46 |
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3460740 | 0.84 | CNR1 (0.51) | CNR1CNR2 | |
| SCHEMBL2642022 | 0.75 | CNR1 (0.57) | CNR1CNR2HRH2 | |
| SCHEMBL14218452 | 0.74 | CNR2 (0.44) | CNR2 | |
| SCHEMBL3581287 | 0.70 | CNR1 (0.66) | CNR1CNR2HRH2 | |
| SCHEMBL5566980 | 0.70 | CNR1 (0.80) | CNR1CNR2 | |
| Hydrochloric Acid SCHEMBL5644812 | 0.69 | CNR1 (0.82) | CNR1CNR2 | |
| SCHEMBL5561839 | 0.69 | CNR1 (0.98) | CNR1 | |
| SCHEMBL14218514 | 0.65 | NR4A2 (0.45) | CNR2 | |
| SCHEMBL1607227 | 0.64 | CNR1 (0.46) | CNR1CNR2HRH2 | |
| SCHEMBL1606359 | 0.64 | CNR1 (0.46) | CNR1HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080108598-A1 | Pharmaceutical use of substituted amides | NOVO NORDISK A/S (DK) | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108598-A1 | Pharmaceutical use of substituted amides | HSD11B1, HSD3B1, HSD11B2 | CNR1 805/4885CNR2 1206/4885HRH2 423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.